STOCK TITAN

Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Cardinal Health (NYSE: CAH) has launched the Kendall DL™ Multi System in the U.S., a new medical device that enables continuous monitoring of cardiac activity, blood oxygen level, and temperature through a single connection point. This single-patient use monitoring system features innovative cable management and is designed to accompany patients throughout their hospital stay. The system's proprietary design reduces false alarms and motion-related artifacts in ECG tracings, while its single-use nature helps minimize cross-contamination risks. The device incorporates clinically proven technology to enhance patient care efficiency and can be reprocessed through Cardinal Health, potentially improving healthcare providers' financial performance.
Cardinal Health (NYSE: CAH) ha lanciato negli Stati Uniti il Kendall DL™ Multi System, un nuovo dispositivo medico che consente il monitoraggio continuo dell'attività cardiaca, del livello di ossigeno nel sangue e della temperatura tramite un unico punto di connessione. Questo sistema di monitoraggio monouso per singolo paziente presenta una gestione innovativa dei cavi ed è progettato per accompagnare i pazienti durante tutto il loro ricovero ospedaliero. Il design proprietario del sistema riduce i falsi allarmi e gli artefatti legati al movimento nelle tracce ECG, mentre la natura monouso contribuisce a minimizzare i rischi di contaminazione incrociata. Il dispositivo integra una tecnologia clinicamente comprovata per migliorare l'efficienza dell'assistenza ai pazienti e può essere rielaborato tramite Cardinal Health, potenzialmente migliorando le performance finanziarie degli operatori sanitari.
Cardinal Health (NYSE: CAH) ha lanzado en Estados Unidos el Kendall DL™ Multi System, un nuevo dispositivo médico que permite la monitorización continua de la actividad cardíaca, el nivel de oxígeno en sangre y la temperatura a través de un único punto de conexión. Este sistema de monitorización de un solo uso para paciente individual cuenta con una gestión innovadora de cables y está diseñado para acompañar a los pacientes durante toda su estancia hospitalaria. El diseño exclusivo del sistema reduce las falsas alarmas y los artefactos relacionados con el movimiento en los trazados ECG, mientras que su uso único ayuda a minimizar los riesgos de contaminación cruzada. El dispositivo incorpora tecnología clínicamente comprobada para mejorar la eficiencia en el cuidado del paciente y puede ser reprocesado a través de Cardinal Health, lo que podría mejorar el rendimiento financiero de los proveedores de atención médica.
Cardinal Health(NYSE: CAH)는 미국에서 Kendall DL™ Multi System을 출시했습니다. 이 새로운 의료 기기는 단일 연결 지점을 통해 심장 활동, 혈중 산소 수준 및 체온을 지속적으로 모니터링할 수 있습니다. 이 일회용 환자 모니터링 시스템은 혁신적인 케이블 관리 기능을 갖추고 있으며, 환자가 병원에 머무르는 동안 함께 사용할 수 있도록 설계되었습니다. 시스템의 독자적인 설계는 ECG 기록에서 오경보와 움직임 관련 잡음을 줄여주며, 일회용 특성은 교차 오염 위험을 최소화하는 데 도움을 줍니다. 이 장치는 임상적으로 입증된 기술을 통합하여 환자 치료 효율성을 향상시키고, Cardinal Health를 통해 재처리할 수 있어 의료 제공자의 재무 성과 개선에 기여할 수 있습니다.
Cardinal Health (NYSE : CAH) a lancé aux États-Unis le Kendall DL™ Multi System, un nouveau dispositif médical permettant la surveillance continue de l'activité cardiaque, du taux d'oxygène sanguin et de la température via un point de connexion unique. Ce système de surveillance à usage unique pour un seul patient dispose d'une gestion innovante des câbles et est conçu pour accompagner les patients tout au long de leur séjour à l'hôpital. La conception exclusive du système réduit les fausses alertes et les artefacts liés aux mouvements dans les tracés ECG, tandis que son usage unique contribue à minimiser les risques de contamination croisée. L'appareil intègre une technologie cliniquement éprouvée pour améliorer l'efficacité des soins aux patients et peut être retraité via Cardinal Health, ce qui pourrait améliorer la performance financière des prestataires de soins.
Cardinal Health (NYSE: CAH) hat in den USA das Kendall DL™ Multi System eingeführt, ein neues medizinisches Gerät, das eine kontinuierliche Überwachung der Herzaktivität, des Blutsauerstoffgehalts und der Temperatur über einen einzigen Anschluss ermöglicht. Dieses Einweg-Monitoringsystem für einzelne Patienten verfügt über ein innovatives Kabelmanagement und ist darauf ausgelegt, Patienten während ihres gesamten Krankenhausaufenthalts zu begleiten. Das firmeneigene Design des Systems reduziert Fehlalarme und bewegungsbedingte Artefakte in EKG-Aufzeichnungen, während die Einweg-Nutzung das Risiko von Kreuzkontaminationen minimiert. Das Gerät integriert klinisch bewährte Technologie zur Steigerung der Effizienz in der Patientenversorgung und kann über Cardinal Health wiederaufbereitet werden, was die finanzielle Leistung von Gesundheitsdienstleistern verbessern kann.
Positive
  • New product launch expands Cardinal Health's medical device portfolio in the growing patient monitoring market
  • Single-patient use design helps reduce cross-contamination and potential infections, potentially lowering hospital readmissions
  • Proprietary technology reduces false alarms and motion artifacts, improving clinical efficiency
  • Product is eligible for medical device reprocessing, offering potential cost benefits for healthcare providers
Negative
  • None.

Insights

Cardinal Health's new vital sign monitoring system improves clinical workflow and infection control while creating recurring revenue opportunities.

Cardinal Health's new Kendall DL™ Multi System represents a significant advancement in patient monitoring technology. By enabling the continuous monitoring of three essential vital signs (cardiac activity, blood oxygen, and temperature) through a single connection point, the system directly addresses workflow inefficiencies in healthcare settings.

The proprietary design delivers two notable clinical advantages: reduced false "leads off" alarms and fewer motion artifacts in ECG tracings. These improvements help clinicians distinguish between actual patient concerns and technical disruptions, enabling more focused care delivery. The single-patient use design serves as an infection control measure by reducing cross-contamination risks associated with reusable lead wires.

From an operational perspective, the product's built-in cable management system and continuous patient monitoring capability from admission through discharge addresses common pain points in hospital settings. Hospital-acquired infections and readmissions directly impact reimbursement under value-based care models, making infection prevention features financially relevant for healthcare providers.

The system's medical device reprocessing eligibility creates an additional value proposition by potentially extending the product's lifecycle while maintaining its single-patient use benefits. This reflects growing hospital demands for products that balance clinical needs with economic considerations.

For Cardinal Health, this launch strengthens their Kendall DL portfolio and represents a positive development in their medical products segment. The single-patient use model creates recurring revenue opportunities as hospitals must repurchase the system for each new patient, potentially establishing a stable revenue stream if adoption is strong.

Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers 

DUBLIN, Ohio, June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connection. The new Kendall DL™ Multi System is designed to travel with the patient from admission to discharge for smooth transport. It helps improve clinician workflows, provides reliable monitoring to help determine the best course of care, and maximizes value across the hospital.

"This innovative addition to the Kendall DL portfolio removes complexity for busy care teams, and at the same time, helps enhance clinical performance with multi-parameter monitoring," said Rachel Schott, global vice president for specialty products at Cardinal Health. "The product streamlines steps that clinicians must follow to provide effective care and controls common lead wire clutter with its built-in cable management system."

The Kendall DL™ Multi System offers a proprietary design that features clinically proven technology to reduce the incidence of false "leads off" alarms2 (i.e., indications that wires connected to the patient's body are not properly connected), as well as motion-related artifacts in electrocardiogram (ECG) tracings, which are recorded disturbances due to a patient's movement. This yields cleaner ECG tracings and allows clinicians to more effectively prioritize the care they need to administer.

As a single-patient use product, the system helps reduce cross contamination related to reusable lead wires for the monitoring of cardiac activity, blood oxygen level and temperature.1 This helps lower the chance of infection and the need for additional hospital days or readmissions.3 The system is eligible for medical device reprocessing through Cardinal Health. 

"By enabling more efficient workflows and driving clinical excellence, this new solution can potentially support the financial performance of healthcare providers," Schott said. "Expanding our Kendall DL offerings demonstrates our commitment to providing products designed to address multiple clinical and operational challenges across healthcare organizations, and builds upon our legacy of safe, high-quality patient monitoring solutions providers have come to trust."

The Kendall DL™ Multi System is now available for health systems in the U.S. For more information, please visit us here.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

Contacts
Media: Brittany Julian, brittany.julian@cardinalhealth.com
Investors: Matt Sims, matt.sims@cardinalhealth.com 

References:
Cardinal Health Data on File – OEM Grabber Comparisons Report, Dec 2024

1. Brown DQ. Disposable vs reusable electrocardiography leads in development of and cross contamination by resistant bacteria. Crit Care Nurse. 2011 Jun;31(3):62 8. doi: 10.4037/ccn2011874. PMID: 21632593.

2. Albert N, Murray T, Bena J, et al. Differences in alarm events between disposable and reusable electrocardiography lead wires. Am J Crit Care. 2015 Jan;24(1):67-73; quiz 74. doi: 10.4031/ajcc2015663.

3. Saunders R, Hansson Hedblom A. The economic implications of introducing single patient ECG systems for cardiac surgery in Australia. Clinicoecon Outcomes Res. 2021 Aug 13;13:727-735. doi: 10.2147/CEOR.S232527

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-launches-new-medical-device-for-the-continuous-monitoring-of-three-essential-vital-signs-in-one-system-302472338.html

SOURCE Cardinal Health

FAQ

What is Cardinal Health's new Kendall DL Multi System and what does it monitor?

The Kendall DL Multi System is a multi-parameter, single-patient use monitoring device that continuously monitors cardiac activity, blood oxygen level, and temperature through a single connection point

How does the CAH Kendall DL Multi System improve patient care?

It reduces false alarms, minimizes motion-related artifacts in ECG tracings, helps prevent cross-contamination, and streamlines clinical workflows through its single-point connection and cable management system

Is Cardinal Health's Kendall DL Multi System reusable?

No, it's a single-patient use product, but it is eligible for medical device reprocessing through Cardinal Health

When will the Kendall DL Multi System be available?

The system is already available for health systems in the United States as of June 2025

What are the key benefits of CAH's Kendall DL Multi System for hospitals?

The system offers improved clinical workflows, reduced cross-contamination risks, better cable management, fewer false alarms, and potential financial benefits through medical device reprocessing
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Latest News

CAH Stock Data

36.55B
238.03M
0.25%
89.03%
2.68%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN